News
NVYTF
0.501
NaN%
--
Novacyt launches enhanced DPYD assay to boost safety of chemotherapy
TipRanks · 2d ago
Novacyt announces immediate departure of Chief Scientific Officer
TipRanks · 05/07 09:03
Novacyt Updates Market on Liquidity Agreement Trades and Voting Rights
TipRanks · 05/05 13:12
Novacyt Earnings Call Balances Progress With Cash Strain
TipRanks · 05/05 00:04
Novacyt S.A. GAAP EPS of -£0.32, revenue of £20M
Seeking Alpha · 04/30 15:35
Novacyt beats 2025 forecasts as genomic diagnostics growth offsets RUO slowdown
TipRanks · 04/30 06:23
Novacyt Sets Date for 2025 Results and Highlights Strategy Behind Australian Expansion
TipRanks · 04/08 06:12
Novacyt Reports March Liquidity Activity and Confirms Total Voting Rights
TipRanks · 04/01 11:25
Novacyt Directors Boost Stakes as Molecular Diagnostics Group Expands Global Reach
TipRanks · 03/30 15:44
Novacyt Raises €785k in Oversubscribed Rights Issue to Back SCD Acquisition
TipRanks · 03/20 07:08
Novacyt Updates Liquidity Agreement Activity and Confirms Total Voting Rights
TipRanks · 03/02 15:54
Novacyt launches rights issue to fund SCD deal and bolster balance sheet
TipRanks · 03/02 08:29
Novacyt Completes Acquisition of Southern Cross Diagnostics
TipRanks · 03/02 07:36
Novacyt buys Australian distributor Southern Cross Diagnostics to boost APAC growth
TipRanks · 02/23 07:23
Novacyt Reports January Liquidity Agreement Trades and Confirms Total Voting Rights
TipRanks · 02/02 15:47
Novacyt’s Yourgene Wins Renewal of Major NIPT Contract with St George’s
TipRanks · 01/27 07:18
Novacyt Delivers In-Line 2025 Revenues as New Genomic Instruments Drive Growth
TipRanks · 01/21 07:22
Novacyt Updates Market on December Liquidity Operations and Voting Rights
TipRanks · 01/02 13:32
Novacyt Provides Monthly Update on Liquidity Agreement and Voting Rights
TipRanks · 12/01/2025 12:03
Novacyt Updates on Liquidity Agreement and Voting Rights
TipRanks · 11/03/2025 14:32
More
Webull provides a variety of real-time NVYTF stock news. You can receive the latest news about Novacyt through multiple platforms. This information may help you make smarter investment decisions.
About NVYTF
Novacyt SA is a France-based company providing biotechnological solutions. The Company develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. It provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The Company develops secure automated cytology named NovaPrep Processor System. It offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. It creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.